Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic Colorectal Cancer.

Current treatment options in oncology - 5 Jul 2021

Diehl Thomas M, Abbott Daniel E

Abstract excerpt

OPINION STATEMENT: Treatment for metastatic colorectal cancer (CRC) has changed significantly over the last few decades as cytotoxic and targeted chemotherapies have evolved and resection of (technically feasible) colorectal liver metastases (CRLM) has become standard of care for eligible patients. Overall, survival for metastatic CRC has considerably improved, but recurrences are common. Numerous clinical risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Decision-Making
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Management

Share to Disease Susceptibility

Share to Hepatectomy

Share to Microsatellite Instability

Share to Molecular Diagnostic Techniques

Share to Patient Selection

Source

Open in PubMed Open full text

Identifiers

PMID: 34224023
DOI: 10.1007/s11864-021-00878-5
PMCID: PMC8561774

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic Colorectal Cancer.PMID 34224023Read ↗

Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.Semantic proximity Read ↗

The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches.Semantic proximity Read ↗

Integrative Genomic and Clinical Profiling of Colorectal Cancer Liver Metastases to Guide Personalized Surgery and Liver Transplantation.Semantic proximity Read ↗

A critical appraisal of the current landscape of resectable BRAF mutated colorectal liver metastases: a systematic review.Semantic proximity Read ↗

The genomics of liver metastases from colon and rectal cancer: An Invited Commentary (invitation from Lee Ocuin, MD and Kevin Behrns, MD) for the special issue of "Management of Advanced Primary and Secondary Liver Malignancies".Semantic proximity Read ↗

Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making.Semantic proximity Read ↗

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.Semantic proximity Read ↗

Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.Semantic proximity Read ↗

Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis.Semantic proximity Read ↗

BRAF V600E-Mutant Colorectal Cancers with Liver-Only Metastases: A Retrospective Study.Semantic proximity Read ↗

Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.Semantic proximity Read ↗

Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.